Pegcetacoplan Safety: Panel Recap

Related

• 

  Early Progression of Atrophy in AMD: Post Hoc Analysis From the GATHER1 Study

  David R Lally, MD

  Annual Meeting Talks

  2022

• 

  Clinical and Demographic Factors Associated With Loss to Follow-up in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  Durga Borkar, MD

  Annual Meeting Talks

  2021

• 

  Avacincaptad Pegol, A Novel C5 Inhibitor, Reached Statistical Significance in a Pivotal Clinical Trial for Geographic Atrophy Secondary to Dry AMD

  Baruch D. Kuppermann, MD, PhD

  Annual Meeting Talks

  2020